Tech Company Financing Transactions
Scailyte Funding Round
Mirabaud Asset Management and private investors invested in a $6 million capital raise for Scailyte. The round was recorded on 10/1/2022.
Transaction Overview
Company Name
Announced On
10/1/2022
Transaction Type
Venture Equity
Amount
$6,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to accelerate growth, expand operations and its business reach.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
Lichtstrasse 35
Basel, 4056
Switzerland
Basel, 4056
Switzerland
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Scailyte is an ETH Zürich spin-off with a best-in-class artificial intelligence platform for the discovery of complex disease patterns from single-cell data. The performance and clinically-relevant applications of Scailyte's platform ScaiVision have been demonstrated in well established CAR-T cell therapies and various clinical projects in Oncology and Immunology.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Peter Nestorov
Chief Financial Officer
Anna Dimitrova
Chief Operating Officer
Corinne Solier
VP - Bus. Development
Juana Flores-Candia
Browse more venture capital transactions:
Prev: 10/1/2022: PetPair venture capital transaction
Next: 10/2/2022: OneD Battery Sciences venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to document every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs